Search results
Disc Medicine (NASDAQ:IRON) Receives “Outperform” Rating from BMO Capital Markets
ETF DAILY NEWS· 5 hours agoBMO Capital Markets restated their outperform rating on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a research note issued to investors on Monday ...
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Short Interest Down 16.9% in May
ETF DAILY NEWS· 21 hours agoPraxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) saw a significant decline in short interest in May. As of May 31st, there was short interest ...
Mubadala Investment Co PJSC Invests $7.97 Million in Revolution Medicines, Inc. (NASDAQ:RVMD)
ETF DAILY NEWS· 1 day agoMubadala Investment Co PJSC acquired a new position in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) in the 4th quarter, according to ...
Disc Medicine, Inc. (NASDAQ:IRON) Shares Acquired by Perceptive Advisors LLC
ETF DAILY NEWS· 2 days agoPerceptive Advisors LLC raised its holdings in Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 14.2% in the fourth quarter, according to its most recent ...
Shareholders Will Most Likely Find Revolution Medicines, Inc.'s (NASDAQ:RVMD) CEO Compensation...
Simply Wall St. via Yahoo Finance· 4 days ago(NASDAQ:RVMD) over the last few years, earnings growth has been disappointing, which suggests...
Could Structure Therapeutics Become the Next Novo Nordisk?
Motley Fool via Yahoo Finance· 18 hours agoStructure Therapeutics (NASDAQ: GPCR) and Novo Nordisk (NYSE: NVO) have one big thing in common: the...
Chimerix (NASDAQ:CMRX) Stock Price Passes Below Two Hundred Day Moving Average of $0.99
ETF DAILY NEWS· 5 hours agoShares of Chimerix, Inc. (NASDAQ:CMRX – Get Free Report) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving ...
JPMorgan Chase & Co. Raises Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $1,150.00
ETF DAILY NEWS· 5 hours agoRegeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target raised by JPMorgan Chase & Co. from $1,050.00 to $1,150.00 in a report issued on Monday, Benzinga ...
Gilead Sciences, Inc. (NASDAQ:GILD) Short Interest Up 17.2% in May
ETF DAILY NEWS· 5 hours agoGilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) was the target of a significant increase in short interest during the month of May. As of May 31st, there was short interest ...
Clearmind advances alcohol substitute beverage program By Investing.com
Investing.com· 7 days agoClearmind Medicine Inc. (NASDAQ:CMND), (FSE:CWY0), a biotech company specializing in the development...